Target
Apoptosis regulator Bcl-2
Ligand
BDBM177878
Substrate
n/a
Meas. Tech.
Fluorescence Polarisation Assay
IC50
10.00±n/a nM
Citation
 Le Diguarher, TCasara, PStarck, JHenlin, JDavidson, JEMurray, JBGraham, CJChen, IGeneste, OHickman, JDepil, SLe Tiran, ANyerges, MDe Nanteuil, G Indolizine compounds, a process for their preparation and pharmaceutical compositions containing them US Patent  US9603854 Publication Date 3/28/2017 
Target
Name:
Apoptosis regulator Bcl-2
Synonyms:
Apoptosis regulator Bcl-2 Protein | B-cell lymphoma 2 protein (Bcl-2) | BCL-2 | BCL2 | BCL2_HUMAN | Bcl-2 Protein
Type:
Homodimer or heterodimer
Mol. Mass.:
26269.11
Organism:
Homo sapiens (Human)
Description:
P10415
Residue:
239
Sequence:
MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDVGAAPPGAAPAPGIFSSQPGHTPHPAASRDPVARTSPLQTPAAPGAAAGPALSPVPPVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMRPLFDFSWLSLKTLLSLALVGACITLGAYLGHK
  
Inhibitor
Name:
BDBM177878
Synonyms:
US9120791, Example 105 | US9603854, 105
Type:
Small organic molecule
Emp. Form.:
C46H49N5O6
Mol. Mass.:
767.9112
SMILES:
COCCN1CCN(C[C@@H]2Cc3ccccc3CN2C(=O)c2cc3OCOc3cc2-c2cc(C(=O)N(c3ccccc3)c3ccc(O)cc3)c3CCCCn23)CC1
Structure:
Search PDB for entries with ligand similarity: